{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:52:47Z","timestamp":1790301167018,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1NR010162-01A1, RO1CA122292-01"],"award-info":[{"award-number":["RO1NR010162-01A1, RO1CA122292-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1CA124481-01"],"award-info":[{"award-number":["RO1CA124481-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cancer Center Support Grant"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute Grant","doi-asserted-by":"crossref","award":["P30-CA016672"],"award-info":[{"award-number":["P30-CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jpainsymman.2010.02.017","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T04:39:31Z","timestamp":1282451971000},"page":"774-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Subcutaneous Olanzapine for Hyperactive or Mixed Delirium in Patients with Advanced Cancer: A Preliminary Study"],"prefix":"10.1016","volume":"40","author":[{"given":"Ahmed","family":"Elsayem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley H.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Munsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Eardie","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca B.","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timotheos","family":"Paraskevopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2010.02.017_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0885-3924(95)00005-J","article-title":"Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation","volume":"10","author":"Bruera","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1176\/appi.psy.45.2.107","article-title":"Family-perceived distress from delirium-related symptoms of terminally ill cancer patients","volume":"45","author":"Morita","year":"2004","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpsychores.2008.05.017","article-title":"The delirium experience: a review","volume":"65","author":"O\u2019Malley","year":"2008","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jpsychores.2006.10.004","article-title":"Delirium: guidelines for general hospitals","volume":"62","author":"Michaud","year":"2007","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00004714-198505060-00009","article-title":"Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients","volume":"5","author":"Tesar","year":"1985","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib6","first-page":"53","article-title":"Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center","volume":"17","author":"Elsayem","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0885-3924(98)00066-9","article-title":"Sedation for uncontrolled symptoms in a South African hospice","volume":"16","author":"Fainsinger","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S1478951505050352","article-title":"Atypical antipsychotics in the management of delirium: a review of the empirical literature","volume":"3","author":"Boettger","year":"2005","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1592\/phco.27.4.588","article-title":"Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients","volume":"27","author":"Rea","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.jpainsymman.2010.02.017_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005594.pub2","article-title":"Antipsychotics for delirium","author":"Lonergan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1440-1819.2001.00898.x","article-title":"An open pilot trial of olanzapine for delirium in the Korean population","volume":"55","author":"Kim","year":"2001","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1176\/appi.psy.43.3.175","article-title":"An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients","volume":"43","author":"Breitbart","year":"2002","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/ajp.155.7.921","article-title":"5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation","volume":"155","author":"Kapur","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0893-133X(95)00069-P","article-title":"Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial","volume":"14","author":"Beasley","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib15","series-title":"Zyprexa","year":"1997"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0893-133X(01)00365-7","article-title":"Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia","volume":"26","author":"Meehan","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 2","key":"10.1016\/j.jpainsymman.2010.02.017_bib17","first-page":"22","article-title":"The efficacy of rapid-acting intramuscular formulation of olanzapine for positive symptoms","volume":"62","author":"Jones","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.158.7.1149","article-title":"Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia","volume":"158","author":"Wright","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.59.5.441","article-title":"A double-blind, placebo-controlled dose response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia","volume":"59","author":"Breier","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","article-title":"A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania","volume":"21","author":"Meehan","year":"2001","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"Suppl 4","key":"10.1016\/j.jpainsymman.2010.02.017_bib21","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.1016\/S0924-977X(08)70620-5","article-title":"P.3.c.036 Comparison of intramuscular olanzapine and haloperidol for the treatment of delirium","volume":"18","author":"Kim","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM198208053070607","article-title":"Intramuscular or intralipomatous injection?","volume":"307","author":"Cockshott","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejrad.2006.01.008","article-title":"Intramuscular injections into the buttocks: are they truly intramuscular?","volume":"58","author":"Chan","year":"2006","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0885-3924(94)90187-2","article-title":"The use of hypodermoclysis for rehydration in terminally ill cancer patients","volume":"9","author":"Fainsinger","year":"1994","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib25","first-page":"953","article-title":"Continuous SC infusion of narcotics for the treatment of cancer pain: an update","volume":"71","author":"Bruera","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1023\/A:1008274608267","article-title":"Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity","volume":"8","author":"Walker","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib27","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib29","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.2107138","article-title":"The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients","volume":"166","author":"Sessler","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib30","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1001\/jama.289.22.2983","article-title":"Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS)","volume":"289","author":"Ely","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib31","series-title":"Common terminology criteria for adverse events, version 3.0","author":"National Cancer Institute","year":"2003"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib32","first-page":"93","article-title":"Subcutaneous or intramuscular? Confronting a parenteral administration dilemma","volume":"14","author":"Prettyman","year":"2005","journal-title":"Medsurg Nurs"},{"issue":"Suppl 2","key":"10.1016\/j.jpainsymman.2010.02.017_bib33","first-page":"S68","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations","volume":"53","author":"Alldredge","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib35","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1176\/appi.ajp.161.6.1130","article-title":"Polyuria after olanzapine overdose","volume":"161","author":"Etienne","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpainsymman.2004.04.008","article-title":"Olanzapine-induced delirium in a terminally ill cancer patient","volume":"28","author":"Morita","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.02.017_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0885-3924(98)80001-8","article-title":"Re: Memorial Delirium Assessment Scale and commentary","volume":"5","author":"Lawlor","year":"1998","journal-title":"J Pain Symptom Manage"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392410004604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392410004604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:04:13Z","timestamp":1760130253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392410004604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0885392410004604"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.02.017","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous Olanzapine for Hyperactive or Mixed Delirium in Patients with Advanced Cancer: A Preliminary Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}